LITS · Lite Strategy, Inc. · Executive Compensation
Market Cap
$49.00M
Shares
30.41M
Volume · Oct 2
1.01M
Avg daily vol (3M)
430.21K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| David M. Urso | Former President and Chief Executive Officer | $934,046 |
| Justin J. File | Acting Chief Executive Officer, Chief Financial Officer | $912,667 |
| Richard G. Ghalie | Former Chief Medical Officer | $708,134 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David M. Urso | President and Chief Executive Officer | $894,905 |
| Richard G. Ghalie | Chief Medical Officer | $847,123 |
| Justin J. File | Chief Financial Officer | $614,700 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Daniel P. Gold | Former President and Chief Executive Officer and Director | $2,446,640 |
| David M. Urso | President and Chief Executive Officer | $2,101,058 |
| Richard G. Ghalie | Chief Medical Officer | $846,659 |
| Brian G. Drazba | Former Chief Financial Officer | $698,312 |
| Justin J. File | Chief Financial Officer | $321,273 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Daniel P. Gold | Former President and Chief Executive Officer and Director | $2,528,609 |
| David M. Urso | President and Chief Executive Officer | $1,744,152 |
| Richard G. Ghalie | Chief Medical Officer | $1,156,728 |
| Brian G. Drazba | Former Chief Financial Officer | $879,660 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Daniel P. Gold | Former President and Chief Executive Officer and Director | $2,948,575 |
| David M. Urso | President and Chief Executive Officer | $2,120,217 |
| Richard G. Ghalie | Chief Medical Officer | $1,143,096 |
| Brian G. Drazba | Former Chief Financial Officer | $1,098,367 |
| Robert D. Mass | Former Chief Medical Officer | $724,061 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Daniel P. Gold | President, Chief Executive Officer and Director | $2,257,537 |
| David M. Urso | Chief Operating Officer and General Counsel | $1,295,240 |
| Brian G. Drazba | Chief Financial Officer | $981,836 |
| Robert D. Mass | Former Chief Medical Officer | $673,427 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Daniel P. Gold | President, Chief Executive Officer & Director | $1,854,414 |
| David M. Urso | Chief Operating Officer and General Counsel | $1,307,947 |
| Brian G. Drazba | Chief Financial Officer | $842,612 |
| Robert D. Mass | Former Chief Medical Officer | $674,275 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Daniel P. Gold | President, Chief Executive Officer & Director | $2,985,416 |
| David M. Urso | Chief Operating Officer and General Counsel | $1,250,411 |
| Brian G. Drazba | Chief Financial Officer | $1,015,916 |
| Robert D. Mass | Chief Medical Officer | $879,305 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joshua Riezman | Director | Appointed | 2026-02-12 |
| Justin J. File | Director | Appointed | 2026-02-12 |
| Justin J. File | Chief Executive Officer | Appointed | 2025-12-30 |
| Justin J. File | member of the Board | Appointed | 2025-11-18 |
| Justin J. File | Chief Executive Officer | Appointed | 2025-11-18 |
| Thomas C. Reynolds, M.D., Ph.D. | director | Resigned | 2025-10-30 |
| Joshua Riezman | director | Appointed | 2025-08-06 |
| Steven D. Wood | director | Resigned | 2025-08-06 |
| Taheer Datoo | Board of Directors | Resigned | 2025-07-22 |
| Charlie Lee | Board of Directors | Appointed | 2025-07-22 |
| Charlie Lee | Investor Director | Appointed | 2025-07-22 |
| Taheer Datoo | Board | Resigned | 2025-07-22 |
| Justin J. File | Acting Chief Executive Officer | Appointed | 2024-08-02 |
| Frederick W. Driscoll | Chairperson of the Company | Appointed | 2024-07-22 |
| Charles V. Baltic III | Chairperson of the Board | Resigned | 2024-07-22 |
| Justin J. File | Acting Chief Executive Officer | Appointed | 2024-07-22 |
| Sujay R. Kango | director | Resigned | 2023-11-01 |
| Tamar D. Howson | director | Resigned | 2023-11-01 |
| Steven Wood | MEI stockholder representative | Appointed | 2023-11-01 |
| Taheer Datoo | director | Appointed | 2023-11-01 |
| Daniel P. Gold | director | Resigned | 2023-11-01 |
| James Flynn | director | Appointed | 2023-11-01 |
| James Flynn | director | Appointed | 2023-11-01 |
| Taheer Datoo | director | Appointed | 2023-11-01 |
| Steven Wood | director | Appointed | 2023-11-01 |